What It Is
Canine multifocal retinopathy 3 is an inherited retinal disorder classified as a specific CMR subtype, with breed-specific genetic testing and retinal lesion documentation requiring current laboratory verification.
Also Called: CMR3; canine multifocal retinopathy type 3
Abbreviation: CMR3
Breeds Affected: Brazilian Terrier; Coton de Tuléar; Lapponian Herder
The Idiot-Proof Explanation
CMR3 is one specific subtype under the CMR umbrella. The owner-facing reality is similar: the retina can show abnormal lesions, the dog may or may not look visually abnormal at home, and the correct subtype test matters more than casually saying “CMR” and moving on.
What Causes It
CMR3 is inherited and should be handled with subtype-specific test language. The exact breed and lab relationship needs current verification before publication.
The retina is affected, but severity and visible owner signs can vary. Many cases are found through screening.
- Inherited genetic status is the key concern.
- Correct subtype-specific testing matters for breeding programs.
- Lesions may be found on eye exam even when the dog acts visually normal.
- Carrier status matters because breeding two risky dogs can produce affected puppies.
This page stays focused on the CMR3 subtype so testing and breed risk do not get blurred with the broader CMR overview.
What This Means for Life With This Dog
For a pet owner, CMR1 usually means eye screening and knowing whether vision is affected. For breeders, it means genetic testing and smart pairings.
A veterinary ophthalmologist can document retinal findings and help decide whether the dog needs monitoring.
Can It Be Fixed?
CMR1 is not curable. Management is monitoring vision and using genetic testing responsibly for breeding decisions.
Symptoms Owners May Notice
Often found on screening: Many dogs do not show obvious signs at home and are identified through eye exams or genetic testing.
Retinal lesions: A veterinary ophthalmologist may see multifocal retinal changes during a dilated exam.
Possible visual changes: Vision impact can vary, so changes in navigation, hesitation, or bumping into objects should be checked.
Breeding risk: Dogs can matter genetically even when they look fine, which is exactly why testing exists.
Treatment Options
Eye exam: A dilated ophthalmic exam documents retinal changes and helps rule out other retinal disease.
Subtype-specific genetic testing: Use the correct CMR1 test for the breed and lab source. Wrong-test confidence is not useful confidence.
Breeding management: Use results to avoid producing affected puppies and to document clear, carrier, or affected status.
Recovery and Aftercare
Aftercare usually means monitoring and keeping records. Breeding dogs need documented test results and honest use of those results.
What Happens If You Wait
The risk is missing the genetic truth.
Waiting may not change a pet dog’s day-to-day life, but it can allow poor breeding decisions or missed eye monitoring when retinal changes are present.
Cost Reality Check
CMR1 costs are usually tied to eye exams, DNA testing, and breeding documentation.
| Care Level | What It May Include | Estimated Cost |
|---|---|---|
| Initial workup | Ophthalmology exam or initial eye screening. | $150-$500 |
| Ongoing management | Genetic testing and repeat monitoring as needed. | $75-$800+ |
| Severe case | Specialist follow-up if lesions are visually significant or another eye disease is suspected. | $800-$3,000+ |
Test access: Breed panels and individual tests vary in price. Because naturally even DNA billing has options.
Ophthalmology follow-up: Dogs with notable lesions may need more than one exam.
Breeding use: Breeding programs need documentation, not screenshots and optimism.
Budget Reality Check
| Budget Item | Estimated Cost |
|---|---|
| CMR1 DNA test | $75-$250+ |
| Eye exam | $150-$500+ |
| Repeat ophthalmology check | $150-$500+ |
| Breed panel testing | $150-$300+ |
| Advanced diagnostics if needed | $500-$2,000+ |
Lifetime Cost Reality
| Case Pattern | Possible Lifetime Cost |
|---|---|
| Testing-only case | $75-$500+ |
| Monitoring case | $500-$2,000+ |
| Complicated eye case | $1,500-$5,000+ |
Tell Me What I Should Really Expect
CMR3 needs subtype-specific verification before final publish.
The daily owner message may look similar across CMR subtypes, but the breeding and testing message does not. Keep CMR3 separate until current lab and breed data confirm exactly how it should be presented.